{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:56:07Z","timestamp":1777982167630,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["201707010331"],"award-info":[{"award-number":["201707010331"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672629"],"award-info":[{"award-number":["81672629"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872168"],"award-info":[{"award-number":["81872168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072925"],"award-info":[{"award-number":["82072925"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.lfs.2021.119696","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T15:01:32Z","timestamp":1622905292000},"page":"119696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["SWIM domain protein ZSWIM4 is required for JAK2 inhibition resistance in breast cancer"],"prefix":"10.1016","volume":"279","author":[{"given":"Kunxiang","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2021.119696_bb0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"Suppl 2","key":"10.1016\/j.lfs.2021.119696_bb0010","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","article-title":"Clinical implications of the intrinsic molecular subtypes of breast cancer","volume":"24","author":"Prat","year":"2015","journal-title":"Breast"},{"issue":"3","key":"10.1016\/j.lfs.2021.119696_bb0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: a review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.lfs.2021.119696_bb0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc1275","article-title":"The STATs of cancer--new molecular targets come of age","volume":"4","author":"Yu","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2021.119696_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2017.05.033","article-title":"Jak Stat signaling and cancer: opportunities, benefits and side effects of targeted inhibition","volume":"451","author":"Groner","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.lfs.2021.119696_bb0030","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1038\/s41467-018-05852-8","article-title":"Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2\/STAT3 axis","volume":"9","author":"Chang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2021.119696_bb0035","article-title":"Targeting the JAK\/STAT Signaling Pathway for Breast Cancer","author":"Shao","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.lfs.2021.119696_bb0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-3-030-20301-6_14","article-title":"Targeting of JAK-STAT signaling in breast cancer: therapeutic strategies to overcome drug resistance","volume":"1152","author":"Tabassum","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2021.119696_bb0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12885-019-5295-z","article-title":"Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer","volume":"19","author":"Mumin","year":"2019","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.lfs.2021.119696_bb0050","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ccr.2012.10.023","article-title":"JAK2\/STAT5 inhibition circumvents resistance to PI3K\/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer","volume":"22","author":"Britschgi","year":"2012","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.lfs.2021.119696_bb0055","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/sj.leu.2404750","article-title":"TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L\/K mutations","volume":"21","author":"Pardanani","year":"2007","journal-title":"LEUKEMIA"},{"issue":"4","key":"10.1016\/j.lfs.2021.119696_bb0060","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/JTO.0b013e31820d9d11","article-title":"Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer models","volume":"6","author":"Sun","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"21","key":"10.1016\/j.lfs.2021.119696_bb0065","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1158\/1078-0432.CCR-08-0581","article-title":"Acquired resistance to small molecule ErbB2 tyrosine kinase inhibitors","volume":"14","author":"Chen","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.lfs.2021.119696_bb0070","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/ijc.32020","article-title":"Molecular mechanisms of resistance to CDK4\/6 inhibitors in breast cancer: a review","volume":"145","author":"Pandey","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2021.119696_bb0075","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1038\/s41467-018-07258-y","article-title":"Targeting the BRD4\/FOXO3a\/CDK6 axis sensitizes AKT inhibition in luminal breast cancer","volume":"9","author":"Liu","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2021.119696_bb0080","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41467-019-14083-4","article-title":"Enhanced JunD\/RSK3 signalling due to loss of BRD4\/FOXD3\/miR-548d-3p axis determines BET inhibition resistance","volume":"11","author":"Tai","year":"2020","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.lfs.2021.119696_bb0085","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.1158\/1078-0432.CCR-11-1541","article-title":"Heat shock protein 90 inhibitor is synergistic with JAK2 inhibitor and overcomes resistance to JAK2-TKI in human myeloproliferative neoplasm cells","volume":"17","author":"Fiskus","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"43","key":"10.1016\/j.lfs.2021.119696_bb0090","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.lfs.2021.119696_bb0095","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3892\/ijo.2012.1744","article-title":"Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis","volume":"42","author":"Komatsu","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.lfs.2021.119696_bb0100","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.lfs.2021.119696_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jsbmb.2017.02.001","article-title":"Colonic transcriptional response to 1alpha,25(OH)2 vitamin D3 in African- and European-Americans","volume":"168","author":"Alleyne","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.lfs.2021.119696_bb0110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bmcl.2017.12.041","article-title":"Novel VDR antagonists based on the GW0742 scaffold","volume":"28","author":"Teske","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.lfs.2021.119696_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0338-8","article-title":"VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer","volume":"51","author":"Song","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"12","key":"10.1016\/j.lfs.2021.119696_bb0120","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1172\/JCI75661","article-title":"Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth","volume":"124","author":"Barbie","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.lfs.2021.119696_bb0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/omi.2014.0135","article-title":"Triple negative breast cancer: a multi-omics network discovery strategy for candidate targets and driving pathways","volume":"19","author":"Karagoz","year":"2015","journal-title":"Omics"},{"key":"10.1016\/j.lfs.2021.119696_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The role of JAK\/STAT signaling pathway and its inhibitors in diseases","volume":"80","author":"Xin","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"13","key":"10.1016\/j.lfs.2021.119696_bb0135","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1128\/MCB.22.13.4567-4578.2002","article-title":"SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation","volume":"22","author":"Krebs","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"12","key":"10.1016\/j.lfs.2021.119696_bb0140","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.trecan.2017.10.004","article-title":"Targeting oncogenic transcription factors: therapeutic implications of endogenous STAT inhibitors","volume":"3","author":"Heppler","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.lfs.2021.119696_bb0145","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7492904","article-title":"Are Janus kinase inhibitors superior over classic biologic agents in RA patients?","volume":"2018","author":"Kotyla","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2021.119696_bb0150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O\u2019Shea","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"8","key":"10.1016\/j.lfs.2021.119696_bb0155","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1158\/1078-0432.CCR-12-0284","article-title":"Molecular pathways: Jak\/STAT pathway: mutations, inhibitors, and resistance","volume":"19","author":"Quintas-Cardama","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.lfs.2021.119696_bb0160","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0968-0004(02)02140-0","article-title":"SWIM, a novel Zn-chelating domain present in bacteria, archaea and eukaryotes","volume":"27","author":"Makarova","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.lfs.2021.119696_bb0165","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.2147\/CMAR.S174355","article-title":"A novel SWIM domain protein ZSWIM5 inhibits the malignant progression of non-small-cell lung cancer","volume":"10","author":"Xu","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"6","key":"10.1016\/j.lfs.2021.119696_bb0170","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ajhg.2017.10.009","article-title":"A recurrent De novo nonsense variant in ZSWIM6 results in severe intellectual disability without frontonasal or limb malformations","volume":"101","author":"Palmer","year":"2017","journal-title":"Am. J. Hum. Genet."},{"issue":"Pt 2","key":"10.1016\/j.lfs.2021.119696_bb0175","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/bj3520301","article-title":"All natural DR3-type vitamin D response elements show a similar functionality in vitro","volume":"352","author":"Toell","year":"2000","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.lfs.2021.119696_bb0180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1010062929140","article-title":"Molecular nature of the vitamin D receptor and its role in regulation of gene expression","volume":"2","author":"Jurutka","year":"2001","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.lfs.2021.119696_bb0185","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/boneres.2017.23","article-title":"Loss of the vitamin D receptor in human breast and prostate cancers strongly induces cell apoptosis through downregulation of Wnt\/beta-catenin signaling","volume":"5","author":"Zheng","year":"2017","journal-title":"Bone Res."},{"issue":"2","key":"10.1016\/j.lfs.2021.119696_bb0190","doi-asserted-by":"crossref","first-page":"H189","DOI":"10.1152\/ajpheart.00155.2016","article-title":"Antihypertensive effects of peroxisome proliferator-activated receptor-beta\/delta activation","volume":"312","author":"Toral","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"10","key":"10.1016\/j.lfs.2021.119696_bb0195","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1021\/acscombsci.7b00066","article-title":"Parallel chemistry approach to identify novel nuclear receptor ligands based on the GW0742 scaffold","volume":"19","author":"Teske","year":"2017","journal-title":"ACS Comb. Sci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521006822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521006822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T13:41:17Z","timestamp":1731591677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521006822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":39,"alternative-id":["S0024320521006822"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119696","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SWIM domain protein ZSWIM4 is required for JAK2 inhibition resistance in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"119696"}}